410 related articles for article (PubMed ID: 18954299)
1. Early diagnosis and successful treatment of acute antibody-mediated rejection of a renal transplant.
Yang YW; Lin WC; Wu MS; Lee PH; Tsai MK
Exp Clin Transplant; 2008 Sep; 6(3):211-4. PubMed ID: 18954299
[TBL] [Abstract][Full Text] [Related]
2. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
3. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation.
Matsuo N; Yamamoto H; Kobayashi A; Yamamoto I; Mitome J; Maruyama Y; Hayakawa H; Miyazaki Y; Utsunomiya Y; Hosoya T; Yamaguchi Y
Clin Transplant; 2009 Aug; 23 Suppl 20():23-6. PubMed ID: 19594591
[TBL] [Abstract][Full Text] [Related]
4. Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients.
Boratyńska M; Banasik M; Hałoń A; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2711-4. PubMed ID: 18021965
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic plasma exchange for desensitization prior to transplantation in ABO-incompatible renal allografts.
Sivakumaran P; Vo AA; Villicana R; Peng A; Jordan SC; Pepkowitz SH; Klapper EB
J Clin Apher; 2009; 24(4):155-60. PubMed ID: 19658162
[TBL] [Abstract][Full Text] [Related]
6. Rapid accomodation of an A1 renal allograft after preconditioning for ABO-incompatible transplantation.
Allen G; Simpkins CE; Segev D; Warren D; King K; Taube J; Locke J; Baldwin W; Haas M; Chivukula R; Montgomery RA
Contrib Nephrol; 2009; 162():35-46. PubMed ID: 19001812
[TBL] [Abstract][Full Text] [Related]
7. Long-term experience of plasmapheresis in antibody-mediated rejection in renal transplantation.
Brown CM; Abraham KA; O'Kelly P; Conlon PJ; Walshe JJ
Transplant Proc; 2009 Nov; 41(9):3690-2. PubMed ID: 19917368
[TBL] [Abstract][Full Text] [Related]
8. Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case report.
Manitpisitkul W; Wilson N; Cooper M; Gurk-Turner C; Hurley H; Rasetto F; KuKuruga D; Barth RN; Philosophe B
Clin Transpl; 2009; ():461-3. PubMed ID: 20524315
[No Abstract] [Full Text] [Related]
9. Effectiveness of rituximab and intravenous immunoglobulin therapy in renal transplant recipients with chronic active antibody-mediated rejection.
Hong YA; Kim HG; Choi SR; Sun IO; Park HS; Chung BH; Choi BS; Park CW; Kim YS; Yang CW
Transplant Proc; 2012 Jan; 44(1):182-4. PubMed ID: 22310610
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.
Walsh RC; Everly JJ; Brailey P; Rike AH; Arend LJ; Mogilishetty G; Govil A; Roy-Chaudhury P; Alloway RR; Woodle ES
Transplantation; 2010 Feb; 89(3):277-84. PubMed ID: 20145517
[TBL] [Abstract][Full Text] [Related]
11. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
12. De novo production of donor-specific anti-HLA alloantibodies in early acute humoral renal allograft rejection.
Spriewald BM; Hugo C
Clin Transpl; 2006; ():469-72. PubMed ID: 18365405
[TBL] [Abstract][Full Text] [Related]
13. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients.
Jordan SC; Peng A; Vo AA
Contrib Nephrol; 2009; 162():13-26. PubMed ID: 19001810
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical outcome between high and low baseline anti-ABO antibody titers in ABO-incompatible kidney transplantation.
Chung BH; Lee JY; Kang SH; Sun IO; Choi SR; Park HS; Kim JI; Moon IS; Choi BS; Park CW; Kim YS; Yang CW
Ren Fail; 2011; 33(2):150-8. PubMed ID: 21332336
[TBL] [Abstract][Full Text] [Related]
16. ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab.
Chikaraishi T; Sasaki H; Tsutsumi H; Miyano S; Nakazawa R; Nakano T; Kitajima K; Kudo H; Takahashi T; Sato Y; Kimura K
Transplant Proc; 2008 Dec; 40(10):3445-7. PubMed ID: 19100409
[TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation.
Angelini A; Castellani C; Poli F; Benazzi E; Torregrossa G; Tona F; Gambino A; Caforio AP; Feltrin G; Toscano G; Valente M; Thiene G; Gerosa G
J Heart Lung Transplant; 2008 Dec; 27(12):1357-60. PubMed ID: 19059119
[TBL] [Abstract][Full Text] [Related]
19. [Antibody-mediated acute rejection].
Lefaucheur C; Nochy D; Glotz D
Nephrol Ther; 2008 Oct; 4 Suppl 3():S188-91. PubMed ID: 19000885
[TBL] [Abstract][Full Text] [Related]
20. Reversibility from delayed hyperacute rejection in ABO-incompatible renal transplantation: histopathological findings of renal allograft biopsy.
Sugiyama K; Arai K; Aikawa A; Miyagi M; Ohara T; Hasegawa A; Muramatsu M; Hirayama N; Tajima E; Kawamura T; Ogihara H; Hadano T; Nakano H
Transplant Proc; 2005 Mar; 37(2):701-4. PubMed ID: 15848507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
